Vaccinations Against COVID-19 May Have Averted Up To 140,000 Deaths In The United States

Sumedha Gupta, Jonathan H. Cantor, Kosali Ilayperuma Simon, Ana I. Bento, Coady Wing, Christopher M. Whaley

ResearchPosted on rand.org Apr 27, 2023Published in: Health Affairs, Volume 40, No. 9, pages 1465-1472 (September 2021). doi: 10.1377/hlthaff.2021.00619

COVID-19 vaccination campaigns continue in the United States, with the expectation that vaccines will slow transmission of the virus, save lives, and enable a return to normal life in due course. However, the extent to which faster vaccine administration has affected COVID-19-related deaths is unknown. We assessed the association between US state-level vaccination rates and COVID-19 deaths during the first five months of vaccine availability. We estimated that by May 9, 2021, the US vaccination campaign was associated with a reduction of 139,393 COVID-19 deaths. The association varied in different states. In New York, for example, vaccinations led to an estimated 11.7 fewer COVID-19 deaths per 10,000, whereas Hawaii observed the smallest reduction, with an estimated 1.1 fewer deaths per 10,000. Overall, our analysis suggests that the early COVID-19 vaccination campaign was associated with reductions in COVID-19 deaths. As of May 9, 2021, reductions in COVID-19 deaths associated with vaccines had translated to value of statistical life benefit ranging between $625 billion and $1.4 trillion.

Topics

Document Details

  • Publisher: Health Affairs
  • Availability: Non-RAND
  • Year: 2021
  • Pages: 8
  • DOI: https://doi.org/10.7249/pubs
  • Document Number: EP-70044

This publication is part of the RAND external publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.